Genetron Holdings Enters Privatization Agreement with Consortium
Beijing-based Genetron Holdings Ltd (NASDAQ: GTH) has officially entered into a privatization and merger agreement...
Ascentage Pharma Initiates Phase III Study for APG-2575 and Calquence in CLL/SLL
Suzhou-based Ascentage Pharma (HKG: 6855) has announced the approval to commence a global multi-center, randomized,...
Betta Pharmaceuticals Secures NMPA Approval for Befotertinib in NSCLC Treatment
China-based Betta Pharmaceuticals Co., Ltd. (SHE: 300558) has officially announced its receipt of market approval...
KPC Pharmaceuticals Secures WHO Prequalification for Dihydroartemisinin/Piperaquine
Yunnan-based KPC Pharmaceuticals Inc. (SHA: 600422) has announced that its dihydroartemisinin/piperaquine 40mg/320mg formulation has received...
Novartis Halts Phase II Clinical Study for MIJ821 in Major Depressive Disorder
Novartis (NYSE: NVS), the Swiss pharmaceutical giant, has decided to hold the Phase II clinical...
MSD’s Keytruda Achieves Primary Endpoint in Late-Stage NSCLC Trial
Merck, Sharp & Dohme (MSD; NYSE: MRK) has announced that a late-stage trial for its...
Bayer AG Plans Continued Investment in China Amidst Global Challenges
Germany-based multinational corporation Bayer AG (ETR: BAYN) is determined to continue investing in China, as...
Novo Nordisk Halts Phase III Ozempic Study on Renal Impairment in Diabetes Patients
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has decided to discontinue a Phase III global...
BMS Expands CAR-T Collaboration with Cellares on Automation Tech
Bristol-Myers Squibb (BMS; NYSE: BMY) has entered into a technology transfer agreement with US-based Cellares,...
Henlius Pharmaceutical Secures GMP Compliance for PD-1 Inhibitor Serplulimab in Indonesia
Shanghai Henlius Pharmaceutical Co., Ltd (HKG: 2696) has announced that its partner, PT Kalbe Genexine...
Medilink Therapeutics Enters Global Licensing Agreement with BioNTech for HER3-Targeted Antibody Drug Conjugates
Suzhou-based Medilink Therapeutics has announced a strategic cooperation and global licensing agreement with Germany-headquartered BioNTech...
Jiangsu BioPerfectus Secures NMPA Approval for Norovirus Nucleic Acid Detection Kit
China-based Jiangsu BioPerfectus Technologies Co., Ltd (SHA: 688399), a leading manufacturer of in vitro diagnostic...
Kintor Pharmaceutical Secures NMPA Approval for Phase II Study of GT1708F in Idiopathic Pulmonary Fibrosis
China-based Kintor Pharmaceutical Ltd (HKG: 9939) has announced that it has received approval from the...
Yiling Pharmaceutical Secures NMPA Approval for Phase I Study of G201-Na in Premenopausal Women
China-based Yiling Pharmaceutical Co., Ltd (SHE: 002603) has announced that it has received approval from...
Gritgen Therapeutics Commences Operations of Commercial GMP Facilities in Suzhou
Suzhou-based gene therapy specialist, Gritgen Therapeutics Co., Ltd, has announced the validation completion and initiation...
GenFleet Therapeutics’ CDK9 Inhibitor SLS009 Earns Orphan Drug Status for AML
Shanghai-based biotechnology company GenFleet Therapeutics has announced that its CDK9 inhibitor, SLS009 (GFH009), has received...
Cochlear’s Artificial Cochlear Sound Processor Gains NMPA Approval for Marketing in China
Australia-based Cochlear has received marketing approval from the National Medical Products Administration (NMPA) for its...
Jiangsu Recbio Forms Strategic Cooperation for Vaccine Production in Zimbabwe
China-based Jiangsu Recbio Technology Co., Ltd (HKG: 2179) has announced a tripartite strategic cooperation agreement...
Roche’s Forimtamig Receives Tacit Approval for Multiple Myeloma Clinical Trials
The Center for Drug Evaluation (CDE) has indicated that Swiss pharmaceutical giant Roche (SWX: ROG)...
Sanofi Partners with BioMap to Accelerate AI-Driven Drug Discovery
France-based pharmaceutical giant Sanofi (EPA: SAN) has entered into a strategic partnership with US biotech...